1. Home
  2. DXLG vs CPIX Comparison

DXLG vs CPIX Comparison

Compare DXLG & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Destination XL Group Inc.

DXLG

Destination XL Group Inc.

HOLD

Current Price

$0.90

Market Cap

50.3M

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.72

Market Cap

59.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXLG
CPIX
Founded
1976
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
59.5M
IPO Year
1987
2009

Fundamental Metrics

Financial Performance
Metric
DXLG
CPIX
Price
$0.90
$4.72
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
318.5K
249.1K
Earning Date
12-11-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$442,120,000.00
$41,278,349.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.21
52 Week Low
$0.83
$1.85
52 Week High
$3.10
$7.25

Technical Indicators

Market Signals
Indicator
DXLG
CPIX
Relative Strength Index (RSI) 42.04 63.04
Support Level $0.88 $4.52
Resistance Level $0.95 $5.08
Average True Range (ATR) 0.06 0.44
MACD -0.00 -0.03
Stochastic Oscillator 4.96 57.41

Price Performance

Historical Comparison
DXLG
CPIX

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: